Effect of urea on the hemagglutinating and complement-fixing antigens of type 2 Dengue virus
- PMID: 4674080
- PMCID: PMC419317
- DOI: 10.1128/iai.6.6.952-957.1972
Effect of urea on the hemagglutinating and complement-fixing antigens of type 2 Dengue virus
Abstract
Sephadex G-200 filtration was used for fractionating dengue type 2 (DEN-2)-infected suckling mouse brain (SMB) supernatant fluids. The high-molecular-weight fraction, which was eluted in the void volume, showed no increase in type specificity when tested against immune ascitic fluid to the four prototype dengue viruses. A void-volume fraction obtained after the infected SMB supernatant fluids were treated with urea displayed significant increases in complement fixation (CF) type specificity. Immune ascitic fluid prepared against the more typespecific DEN-2 antigen demonstrated neutralizing ability and greater CF type specificity. When DEN-2 sucrose-acetone-extracted hemagglutinating (HA) antigens were treated with 6 m urea at 37 C for various time intervals, all HA antigen was destroyed in 15 min. Urea treatment of infected SMB supernatant fluids indicated that the CF antigens were more stable to the effect of urea than were the HA antigens. After urea treatment of the SMB supernatant fluids, the CF type specificity increased as the hemagglutination inhibition titer decreased.
Similar articles
-
Rapid complement fixation technique for estimating complement-fixing antigen elution profiles of viruses from gel filtration columns.Appl Microbiol. 1972 Jul;24(1):157-9. doi: 10.1128/am.24.1.157-159.1972. Appl Microbiol. 1972. PMID: 5057370 Free PMC article.
-
Dengue viral antigens in host cell membranes.Acta Virol. 1978 Jan;22(1):31-6. Acta Virol. 1978. PMID: 25005
-
Human antibody to dengue soluble complement-fixing (SCF) antigens.J Immunol. 1973 Dec;111(6):1804-9. J Immunol. 1973. PMID: 4201557 No abstract available.
-
Use of sarcoma 180 to prepare hemagglutinating and complement-fixing antigens for viruses in adult mice.Proc Soc Exp Biol Med. 1971 Apr;136(4):1355-9. doi: 10.3181/00379727-136-35491. Proc Soc Exp Biol Med. 1971. PMID: 5554486 No abstract available.
-
Partial purification and characterization of a dengue virus soluble complement-fixing antigen.J Immunol. 1970 Dec;105(6):1565-8. J Immunol. 1970. PMID: 5483833 No abstract available.
Cited by
-
Early clinical and laboratory risk factors of intensive care unit requirement during 2004-2008 dengue epidemics in Singapore: a matched case-control study.BMC Infect Dis. 2014 Dec 5;14:649. doi: 10.1186/s12879-014-0649-2. BMC Infect Dis. 2014. PMID: 25475217 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources